Next Biometrics Group ASA (OSTO:NEXTO) EBITDA Margin %: -1,682.63% (As of Mar. 2026)


OSTO:NEXTO Next Biometrics Group ASA OSTO:NEXTO
33 GF Score
Price kr9.64
GF Value kr37.70
! 5 Warning Signs
View Full Analysis

What is Next Biometrics Group ASA EBITDA Margin %?

Next Biometrics Group ASA OSTO:NEXTO 33 EBITDA Margin % is -1,682.63% as of Mar. 2026. GuruFocus rates OSTO:NEXTO with a GF Score™ of 33/100 and a GF Value™ of kr37.70. The stock has 5 warning signs investors should review. Among 2,472 Hardware companies, Next Biometrics Group ASA ranks worse than 99.35% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Next Biometrics Group ASA's EBITDA for the three months ended in Mar. 2026 was kr-30.32 Mil. Next Biometrics Group ASA's Revenue for the three months ended in Mar. 2026 was kr1.80 Mil. Therefore, Next Biometrics Group ASA's EBITDA margin for the quarter that ended in Mar. 2026 was -1,682.63%.


Next Biometrics Group ASA  (OSTO:NEXTo) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Next Biometrics Group ASA EBITDA Margin % Related Terms


Next Biometrics Group ASA EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Next Biometrics Group ASA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Next Biometrics Group ASA EBITDA Margin % Chart

Next Biometrics Group ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.44 -80.83 -169.06 -352.47 -565.20

Next Biometrics Group ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -513.90 854.72 -600.57 -1,134.32 -1,682.63

OSTO:NEXTO vs COHR, KEYS, GRMN: EBITDA Margin % Comparison

For the Scientific & Technical Instruments subindustry, Next Biometrics Group ASA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Next Biometrics Group ASA EBITDA Margin % vs Hardware Industry

For the Hardware industry and Technology sector, Next Biometrics Group ASA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Next Biometrics Group ASA's EBITDA Margin % falls into.


OSTO:NEXTO
33GF Score
Next Biometrics Group ASA OSTO:NEXTO
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Next Biometrics Group ASA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Next Biometrics Group ASA's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-75.528/13.363
=-565.20 %

Next Biometrics Group ASA's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-30.321/1.802
=-1,682.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -1,682.63% mean?
Next Biometrics Group ASA (OSTO:NEXTO) has a EBITDA Margin % of -1,682.63% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Next Biometrics Group ASA and its competitors. According to the industry distribution chart, Next Biometrics Group ASA ranks #2456 out of 2472 companies in the Hardware industry, placing it in the top 99.4%.
Is Next Biometrics Group ASA's EBITDA Margin % too high?
Next Biometrics Group ASA's current EBITDA Margin % is -1,682.63%. Based on the distribution chart, Next Biometrics Group ASA ranks #2456 out of 2472 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Next Biometrics Group ASA has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Next Biometrics Group ASA's EBITDA Margin % compare to COHR and KEYS?
According to the Hardware industry distribution chart, Next Biometrics Group ASA ranks #2456 out of 2472 companies for EBITDA Margin %. This places Next Biometrics Group ASA in the lower half of its industry. The industry median EBITDA Margin % is 7.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Hardware company?
The median EBITDA Margin % among Hardware companies is 7.01, based on 2,472 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Next Biometrics Group ASA and its competitors. For the Hardware industry, the median EBITDA Margin % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Next Biometrics Group ASA's current EBITDA Margin % is -1,682.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Next Biometrics Group ASA stock overvalued right now?
Next Biometrics Group ASA (OSTO:NEXTO) has a current EBITDA Margin % of -1,682.63%. The stock's GF Value™ is kr37.70, compared to a current price of kr9.64 — trading 74.4% below its estimated fair value. The current EBITDA Margin % is -1,682.63%. Next Biometrics Group ASA's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Next Biometrics Group ASA (OSTO:NEXTO), the current EBITDA Margin % is -1,682.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Next Biometrics Group ASA (OSTO:NEXTO) Overvalued in 2026?

Based on GuruFocus' analysis, Next Biometrics Group ASA stock appears to be undervalued. The current stock price of kr9.64 is trading 74.4% below its estimated GF Value™ of kr37.70.

Key valuation signals for OSTO:NEXTO:

  • EBITDA Margin %: -1,682.63%
  • GF Value™: kr37.70 vs. price of kr9.64 (74.4% below fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the OSTO:NEXTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Next Biometrics Group ASA Business Description

Other Exchanges NEXT:Norway0QWK:UK
Address Stortorvet 7, Oslo, NOR, 0155
Next Biometrics Group ASA provides fingerprint sensor technology and products. The company's products are utilized for Smart Card, Government ID, Access control, Notebook, and others. The company's products include smart card solutions, fingerprint sensor modules, fingerprint readers, Aadhar products, Software DevKits, and Hardware DevKits. The company has one operating segment namely; Fingerprint sensor Technology. The company's Geographic customer base consists of Asia (Japan and India), Europe (France and Germany) and North America.
33GF Score

Get the complete analysis for OSTO:NEXTO

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.64
Price
kr37.70
GF Value